Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical issues and hormone replacement therapy.

Patricia F Harris1

  • 1Washington Hospital Center, Geriatrics and Long Term Care, Room 2B-39, 110 Irving Street, NW, Washington, DC 20010, USA. patricia.f.harris@medstar.net

Current Women'S Health Reports
|September 7, 2002
PubMed
Summary

Postmenopausal hormone replacement therapy (HRT) presents risks like blood clots and breast cancer, but long-term use may reduce cardiovascular events and dementia. Lower doses might balance benefits and risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breaking down Silos to improve the health of older adults: The case for medicare to cover home safety renovations.

Ageing research reviews·2020
Same author

Update in Hospital Palliative Care: Symptom Management, Communication, Caregiver Outcomes, and Moral Distress.

Journal of hospital medicine·2017
Same author

Review: Palliative care improves quality of life and symptom burden but does not affect mortality at 1 to 3 months.

Annals of internal medicine·2017
Same author

To stent or not to stent: an evidence-based approach to palliative procedures at the end of life.

Journal of pain and symptom management·2012
Same author

Update in palliative care--2011.

Journal of general internal medicine·2011
Same author

Prevalence and treatment of menopausal symptoms among breast cancer survivors.

Journal of pain and symptom management·2002

Area of Science:

  • Reproductive Medicine
  • Gerontology
  • Oncology

Background:

  • Postmenopausal hormone replacement therapy (HRT) remains a topic of significant debate.
  • Established risks include venous thrombotic events and breast cancer, though absolute risks are often small.
  • Concerns also exist regarding cardiovascular events, quality of life, and urinary incontinence.

Purpose of the Study:

  • To review the current evidence on the risks and benefits of postmenopausal hormone replacement therapy (HRT).
  • To evaluate the association between HRT and various health outcomes, including thrombotic events, cancer, cardiovascular disease, and dementia.

Main Methods:

  • Review of randomized controlled trials and longitudinal studies.
  • Analysis of associations between HRT use and specific health outcomes.

Main Results:

  • Confirmed link between HRT and venous thrombotic events; stronger evidence for breast cancer association.
  • Randomized trials suggest HRT may be linked to cardiovascular events in women with existing heart disease, diminished quality of life, and worsened urinary incontinence.
  • Longitudinal studies indicate long-term HRT use is associated with reduced cardiovascular events and lower dementia risk.

Conclusions:

  • HRT use has demonstrated both risks and potential long-term benefits, including cardiovascular protection and reduced dementia incidence.
  • Further research into lower daily doses of HRT may offer a way to mitigate risks while preserving therapeutic advantages.
  • The decision to use HRT requires careful consideration of individual risk factors and potential benefits.

Related Experiment Videos